Skip to main content

Table 1 ROP staging, zones, and disease course of studied patients

From: Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity

 

Pretreatment stage (percentage to total)

Total

No regression/total

Recurrence/regressed

Complete vascularization/regressed without recurrence

1.00

2.00

3.00

   

Pretreatment zone

1

2 (0.2%)

8 (0.9%)

177 (20.4%)

187 (21.6%)

18/187 (9.6%)

13/169 (7.6%)

112/156 (71.7%)

2

0

25 (2.8%)

653 (75.5%)

678 (78.3%)

17/678 (2.5%)

20/661 (3.0%)

506/641 (78.9%)

Total

2 (0.2%)

33 (3.8%)

830 (95.9%)

865 (100%)

35/865 (4.0%)

33/830 (3.9%)

608/797 (76.2%)